Ticagrelor 90mg: Clinical Trials

20 trials of Ticagrelor 90mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 4 unknown, 1 recruiting, 1 terminated. 6 Phase 3, 4 Phase 4, 3 Not applicable, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 36Completed 3, Recruiting 1, Terminated 1, Unknown 1
Phase 44Completed 2, Unknown 2
Not applicable3Completed 3
Phase 22Completed 2
Phase 11Completed 1

Follow Ticagrelor 90mg: new trials by email Literature Review of Ticagrelor 90mg trials Research Report on Ticagrelor 90mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg - Stroke, Stroke, Ischemic
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris28002023-05-172025-09-08
Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
Ticagrelor 90mg, Ticagrelor 60mg, Aspirin - STEMI, NSTEMI
Phase 3UnknownCollegium Medicum w Bydgoszczy45002022-02-072023-04-21
Ticagrelor Monotherapy After Stenting
Ticagrelor 90mg - Acute Myocardial Infarction
Phase 2CompletedVastra Gotaland Region2002021-12-142026-03-20
Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke
Ticagrelor 90mg, Clopidogrel 75 mg - Ischemic Stroke, Transient Ischemic Attack
Phase 3CompletedMazandaran University of Medical Sciences902021-08-082023-10-19
Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
Ticagrelor 90mg, Ticagrelor 60 mg - Acute Coronary Syndrome, STEMI
Phase 3CompletedFederico II University502021-04-012022-07-07
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
Prasugrel 10mg, Ticagrelor 90mg - Non ST Segment Elevation Acute Coronary Syndrome
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)752021-02-192023-03-06
Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data
Ticagrelor 90mg, Prasugrel 10mg - Acute Coronary Syndrome
CompletedBrigham and Women's Hospital283892020-10-102023-07-27
Early Versus Late Loading of Ticagrelol in Patients With STEMI
Ticagrelor 90mg - Myocardial Infarction
UnknownAssiut University8002020-03-012020-02-12
A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
Ticagrelor 60mg, Ticagrelor 90mg - Acute Coronary Syndrome, Coronary Stent Implantation
Phase 4UnknownShanghai Tong Ren Hospital21202020-02-192023-12-07
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
Ticagrelor 90mg, Clopidogrel 75mg - Antiplatelet
CompletedBrigham and Women's Hospital279602019-09-222023-07-27
LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Ticagrelor 90mg, Ticagrelor 90mg/60mg, Clopidogrel 75mg - Antiplatelet Therapy, Coronary Artery Disease
Phase 4UnknownBeijing Anzhen Hospital2252019-08-302019-08-19
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
Point of care screening for HPR, Ticagrelor 90mg - Peripheral Artery Disease, Clopidogrel, Poor Metabolism of
Phase 3TerminatedMarissa Jarosinski312019-08-092026-07-06
Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease
Ticagrelor 90mg, Clopidogrel 75mg - Platelet Reactivity
Phase 4CompletedFirst Affiliated Hospital of Harbin Medical University502019-07-022022-01-11
Chronic Kidney Disease (CKD) Platelet Study
Ticagrelor 90mg, Clopidogrel 75mg, Aspirin 81 mg - Chronic Kidney Diseases, Heart Attack
Phase 3CompletedUniversity of Arkansas762018-11-012022-12-29
Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
Ticagrelor 90mg, Clopidogrel 75mg, acetylsalicylic acid (ASA) 81mg - Acute Coronary Syndrome
Phase 4CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre10382018-10-012023-11-03
A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With Ticagrelor
Ticagrelor 90mg, Epinephrine, Metoprolol - Healthy Volunteers
Phase 1CompletedVastra Gotaland Region102018-02-282018-05-11
Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)
Clopidogrel, Ticagrelor 90mg - Myocardial Infarction
CompletedCairo University10222017-04-152019-01-14
In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
Ticagrelor 180mg, Ticagrelor 90mg - Coronary Artery Disease
Not applicableCompletedUniversity of Florida602014-04-012017-04-04
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
Ticagrelor 180mg, Prasugrel 10mg, Ticagrelor 90mg - Coronary Artery Disease, Acute Coronary Syndrome
Not applicableCompletedUniversity of Florida822014-03-012024-07-03
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
Ticagrelor 180mg, Ticagrelor 90mg - Coronary Artery Disease
Not applicableCompletedUniversity of Florida602013-01-012015-06-10

Conditions studied

Acute Coronary Syndrome (6)  ·  Coronary Artery Disease (6)  ·  Myocardial Infarction (6)  ·  Ischemic Stroke (3)  ·  Angina, Unstable (2)  ·  Non-ST Elevated Myocardial Infarction (2)  ·  ST Elevation Myocardial Infarction (2)  ·  Stroke (2)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Infarction (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Ischemic Attack, Transient (1)  ·  Peripheral Arterial Disease (1)

Sponsors

University of Florida (3)  ·  Brigham and Women's Hospital (2)  ·  Vastra Gotaland Region (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Beijing Anzhen Hospital (1)  ·  Cairo University (1)  ·  Collegium Medicum w Bydgoszczy (1)  ·  Federico II University (1)  ·  First Affiliated Hospital of Harbin Medical University (1)  ·  Marissa Jarosinski (1)  ·  Mazandaran University of Medical Sciences (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Shanghai Tong Ren Hospital (1)

Countries

United States (7)  ·  China (3)  ·  Sweden (2)  ·  Canada (1)  ·  Egypt (1)  ·  France (1)  ·  Iran (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)

Top investigators

Anders Jeppsson, MD,PhD,Prof (1)  ·  Athena Sharifi-Razavi (1)  ·  Dominick Angiolillo (1)  ·  Dominick Angiolillo, MD, PhD (1)  ·  Dominick J Angiolillo, MD, PhD (1)  ·  Eliano Navarese, MD, PhD (1)  ·  Giovanni Esposito, MD, PhD (1)  ·  Hany R. Maher (1)  ·  Jacek Kubica, MD, PhD (1)  ·  Jain Nishank, MD (1)  ·  James Brophy, MD, PhD (1)  ·  Junbo Ge, Doctor (1)  ·  Lei Hou, Doctor (1)  ·  Shirley Wang, PhD (1)

Results publications

PMID 26117466, PMID 27013060, PMID 30780166, PMID 32675750, PMID 33327727, PMID 34096012, PMID 35048203, PMID 35224730, PMID 35248132, PMID 36682595, PMID 40164463